L
Larry J. Prokop
Researcher at Mayo Clinic
Publications - 226
Citations - 15478
Larry J. Prokop is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 52, co-authored 191 publications receiving 10900 citations.
Papers
More filters
Journal ArticleDOI
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
Parambir S. Dulai,Siddharth Singh,Janki Patel,Meera Soni,Larry J. Prokop,Zobair M. Younossi,Giada Sebastiani,Mattias Ekstedt,Hannes Hagström,Patrik Nasr,Per Stål,Vincent Wai-Sun Wong,Stergios Kechagias,Rolf Hultcrantz,Rohit Loomba +14 more
TL;DR: The risk of liver‐related mortality increases exponentially with increase in fibrosis stage; these data have important implications in assessing the utility of each stage and benefits of regression of fibrosis from one stage to another.
Journal ArticleDOI
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
TL;DR: Based on a meta-analysis of studies of paired liver biopsy studies, liver fibrosis progresses in patients with NAFL and NASH.
Journal ArticleDOI
Sexual Abuse and Lifetime Diagnosis of Psychiatric Disorders: Systematic Review and Meta-analysis
Laura P. Chen,M. Hassan Murad,Molly L Paras,Kristina M. Colbenson,Amelia Sattler,Erin N. Goranson,Mohamed B. Elamin,Richard J. Seime,Gen Shinozaki,Larry J. Prokop,Ali Zirakzadeh +10 more
TL;DR: A history of sexual abuse is associated with an increased risk of a lifetime diagnosis of multiple psychiatric disorders and associations between sexual abuse and depression, eating disorders, and posttraumatic stress disorder were strengthened by a history of rape.
Journal ArticleDOI
Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis
Rohan Khera,Mohammad Hassan Murad,Apoorva K. Chandar,Parambir S. Dulai,Zhen Wang,Larry J. Prokop,Rohit Loomba,Michael Camilleri,Siddharth Singh +8 more
TL;DR: All active agents were associated with significant excess weight loss compared with placebo at 1 year and phentermine-topiramate, naltrexone-bupropion, and liraglutide, each associated with 5% weight loss at 52 weeks, were linked with the highest odds of adverse event-related treatment discontinuation.
Journal ArticleDOI
Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis.
Molly L Paras,Mohammad Hassan Murad,Laura P. Chen,Erin N. Goranson,Amelia Sattler,Kristina M. Colbenson,Mohamed B. Elamin,Richard J. Seime,Larry J. Prokop,Ali Zirakzadeh +9 more
TL;DR: Evidence suggests a history of sexual abuse is associated with lifetime diagnosis of multiple somatic disorders.